Aprecap 150mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient is Aprepitant, which belongs to a class of drugs known as neurokinin-1 (NK1) receptor antagonists. Aprepitant works by blocking the action of a substance called substance P in the brain, which is involved in triggering nausea and vomiting. This makes it particularly effective in preventing chemotherapy-induced nausea and vomiting (CINV), both acute and delayed, as well as preventing postoperative nausea and vomiting (PONV).
Aprecap 150mg Injection is typically administered intravenously by a healthcare professional. The dosage and duration of treatment will depend on the specific type of cancer being treated, the chemotherapy regimen, and the patient’s individual response. It is often used in combination with other antiemetic medications to provide comprehensive protection against nausea and vomiting.
Common side effects may include fatigue, hiccups, constipation, and loss of appetite. Serious side effects are rare but can occur. Patients should inform their doctor about any pre-existing medical conditions, especially liver problems, and any other medications they are taking. Aprecap 150mg Injection should be stored at room temperature, protected from light and moisture. It is crucial to use this medication only as prescribed by a qualified healthcare provider.
